- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 25th, 2005
Jack Uldrich: Last week, privately-held Dendritic NanoTechnologies Inc. (DNT) announced that it had developed a new family of scalable, precision dendrimer nanostructures. The technology is called Priostar ™ and it could radically change the economics of nanotechnology.
The news is not only important for the emerging nanotech industry, it is especially good news for Dow Chemical (NYSE: DOW) and Starpharma (Nasdaq: SPHRY) -- both of whom own 30% of DNT apiece.
|Related News Press|
Molecular trick alters rules of attraction for non-magnetic metals August 5th, 2015
Global Carbon Nanotubes Industry 2015: Acute Market Reports August 4th, 2015
Nanometrics to Participate in the Citi 2015 Global Technology Conference August 26th, 2015
Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015